AI Analysis AI Analysis of NEO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NEO to Watchlist?
  • Easy Tracking In The Watchlist
PDF

NeoGenomics stock price ended at $14.17 on Friday, after gaining 3.20%
(Updated on Jun 26, 2026)

Buy or Hold candidate since May 20, 2026 Gain 59.21%

The NeoGenomics stock price gained 3.20% on the last trading day (Friday, 26th Jun 2026), rising from $13.73 to $14.17. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 4.63% from a day low at $13.60 to a day high of $14.23. The price has risen in 6 of the last 10 days and is up by 23.54% over the past 2 weeks. Volume fell on the last day by -4 million shares and in total, 0 shares were bought and sold for approximately $0 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $12.44, a level that may pose a second chance to hit a runner. According to fan-theory $14.53 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

NEO Signals & Forecast

The NeoGenomics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $12.14 and $10.27. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 17, 2026, and so far it has risen 36.51%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for NeoGenomics stock

On the downside, the stock finds support just below today's level from accumulated volume at $12.90 and $11.47. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, NeoGenomics finds support just below today's level at $12.90. If this is broken, then the next support from accumulated volume will be at $11.47 and $11.13.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.630 between high and low, or 4.63%. For the last week the stock has had daily average volatility of 6.47%

The NeoGenomics stock is extremely overbought on RSI14 (78). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken. Since the NeoGenomics has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Our recommended stop-loss: $13.75 (-2.94%) (This stock has very low daily movements and this gives very low risk. The RSI14 is 78 and this increases the risk substantially. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (NEO) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect NeoGenomics to open at $14.00, and during the day (based on 14 day Average True Range), to move between $13.83 and $14.51, which gives a possible trading interval of +/-$0.675 (+/-4.88%) up or down from last closing price. If NeoGenomics takes out the full calculated possible swing range there will be an estimated 4.88% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $12.90, some $1.27 (8.96%) from the current price of $14.17, our system finds the risk reward attractive.

Is NeoGenomics stock A Buy?

NeoGenomics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $14.00 ( 1.20%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NEO Performance

Trading levels for NEO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 14.63 3.25%
R2 14.39 1.55%
R1 14.24 0.499%
Price 14.17
S1 13.76 -2.90%
S2 13.61 -3.95%
S3 13.37 -5.65%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 14.17
S1 12.90 -8.96%
S2 11.47 -19.05%
S3 11.13 -21.45%

NEO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 15, 2020 Dec 17, 2020 Dec 30, 2020 $0.400 0.738%

FAQ

What is the symbol for NeoGenomics Stock and on which exchange is it traded?
The symbol for NeoGenomics is NEO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NeoGenomics Stock?
NeoGenomics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy NeoGenomics Stock?
NeoGenomics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NeoGenomics Stock.

What's the current price of NeoGenomics Stock?
As of the end of day on the Jun 26, 2026, the price of an NeoGenomics (NEO) share was $14.17.

What is the 52-week high and low for NeoGenomics Stock?
The 52-week high for NeoGenomics Stock is $14.23 and the 52-week low is $4.72.

What is the market capitalization of NeoGenomics Stock?
As of the Jun 26, 2026, the market capitalization of NeoGenomics is 369.02M.

When is the next earnings date for NeoGenomics?
The upcoming earnings date for NeoGenomics is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT NEOGENOMICS
NeoGenomics
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fl...
GOLDEN STAR
Ticker Change Signal Date
JLL
$299.78
5.10% Jun 24
X
XMAX
$8.34
5.40% Jun 24
TWI
$7.56
6.08% Jun 22
IAC
$42.63
5.08% Jun 12
DHI
$146.71
13.35% Jun 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE